Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 692

1.

Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.

De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Di Bartolo P, Pontremoli R; AMD-Annals Study Group.

Nephrol Dial Transplant. 2015 Apr 16. pii: gfv101. [Epub ahead of print]

PMID:
25883195
2.

High hydrostatic pressure processing reduces the glycemic index of fresh mango puree in healthy subjects.

Elizondo-Montemayor L, Hernández-Brenes C, Ramos-Parra PA, Moreno-Sánchez D, Nieblas B, Rosas-Pérez AM, Lamadrid-Zertuche AC.

Food Funct. 2015 Apr 8;6(4):1352-60. doi: 10.1039/c4fo01005a.

PMID:
25797308
3.

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes.

Edwards KL, Minze MG.

Core Evid. 2015 Jan 9;10:11-21. doi: 10.2147/CE.S55944. eCollection 2015. Review.

4.

Gestational diabetes mellitus: Where are we now?

Ashwal E, Hod M.

Clin Chim Acta. 2015 Feb 2. pii: S0009-8981(15)00043-1. doi: 10.1016/j.cca.2015.01.021. [Epub ahead of print]

PMID:
25655741
5.

[Dapagliflozin: Beyond glycemic control in the treatment of type 2 diabetes mellitus.]

Sanz-Serra P, Pedro-Botet J, Flores-Le Roux JA, Benaiges D, Chillarón JJ.

Clin Investig Arterioscler. 2015 Jan 31. pii: S0214-9168(14)00169-7. doi: 10.1016/j.arteri.2014.11.001. [Epub ahead of print] Spanish.

PMID:
25648671
6.

[Cardiovascular risk reduction in the management of diabetic patients: what has changed since the '90s in the clinical approach?].

Consoli A, Di Fulvio P.

G Ital Cardiol (Rome). 2014 Dec;15(12 Suppl 2):21S-26S. doi: 10.1714/1762.19114. Italian.

PMID:
25623547
7.

Estimating Cost-Effectiveness in Type 2 Diabetes: The Impact of Treatment Guidelines and Therapy Duration.

McEwan P, Gordon J, Evans M, Ward T, Bennett H, Bergenheim K.

Med Decis Making. 2015 Jan 16. pii: 0272989X14565821. [Epub ahead of print]

PMID:
25596535
8.

[Guidelines for the management of diabetes mellitus type 2].

Mediavilla Bravo JJ.

Semergen. 2014 Sep;40 Suppl 4:11-8. doi: 10.1016/S1138-3593(14)74392-8. Spanish.

PMID:
25595348
9.
10.

Internet blood glucose monitoring systems provide lasting glycemic benefit in type 1 and 2 diabetes: a systematic review.

Tildesley HD, Po MD, Ross SA.

Med Clin North Am. 2015 Jan;99(1):17-33. doi: 10.1016/j.mcna.2014.08.019. Epub 2014 Oct 18. Review.

PMID:
25456641
11.

Self-monitoring blood glucose test strip use with diabetes medicines in people with types 1 and 2 diabetes in New Zealand.

Metcalfe S, Moodie P, Norris H, Rasiah D.

N Z Med J. 2014 Nov 28;127(1406):48-62.

PMID:
25447249
12.

Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options.

Du YF, Ou HY, Beverly EA, Chiu CJ.

Clin Interv Aging. 2014 Nov 18;9:1963-80. doi: 10.2147/CIA.S53482. eCollection 2014.

13.

Safety and efficacy of dulaglutide, a once weekly GLP-1 receptor agonist, for the management of type 2 diabetes.

Kuritzky L, Umpierrez G, Ekoé JM, Mancillas-Adame L, Landó LF.

Postgrad Med. 2014 Oct;126(6):60-72. doi: 10.3810/pgm.2014.10.2821. Review.

PMID:
25414935
14.

Luseogliflozin for the treatment of type 2 diabetes.

Seino Y.

Expert Opin Pharmacother. 2014 Dec;15(18):2741-9. doi: 10.1517/14656566.2014.978290. Epub 2014 Oct 30. Review.

PMID:
25359155
15.

[Role of classical oral glucose-lowering medications in current treatment].

Carramiñana Barrera FC.

Semergen. 2014 Jul;40 Suppl 2:9-15. doi: 10.1016/S1138-3593(14)74385-0. Spanish.

PMID:
25311715
16.

Empagliflozin for the treatment of type 2 diabetes.

Jahagirdar V, Barnett AH.

Expert Opin Pharmacother. 2014 Nov;15(16):2429-41. doi: 10.1517/14656566.2014.966078. Review.

PMID:
25301180
17.

Glycemic control parameters in insulin-naïve patients with uncontrolled type 2 diabetes referred to endocrinologists, and degree of implementation of the national Spanish consensus for the management of hyperglycemia.

Azriel S, Casal F, Dalama B, Varillas F, Villarroel Á, Soto A, Barberá G.

Endocrinol Nutr. 2014 Dec;61(10):541-7. doi: 10.1016/j.endonu.2014.06.004. Epub 2014 Sep 24. English, Spanish.

PMID:
25260336
18.

Sight-threatening diabetic retinopathy at presentation to screening services in Fiji.

Damato EM, Murray N, Szetu J, Sikivou BT, Emma S, McGhee CN.

Ophthalmic Epidemiol. 2014 Oct;21(5):318-26. doi: 10.3109/09286586.2014.949781. Epub 2014 Aug 26.

PMID:
25157913
19.

The effect of diabetes self-management education on body weight, glycemic control, and other metabolic markers in patients with type 2 diabetes mellitus.

Yuan C, Lai CW, Chan LW, Chow M, Law HK, Ying M.

J Diabetes Res. 2014;2014:789761. doi: 10.1155/2014/789761. Epub 2014 Jul 17.

20.

Comparison of GLP-1 analogues versus sitagliptin in the management of type 2 diabetes: systematic review and meta-analysis of head-to-head studies.

Wang T, Gou Z, Wang F, Ma M, Zhai SD.

PLoS One. 2014 Aug 4;9(8):e103798. doi: 10.1371/journal.pone.0103798. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk